Double mutant MRL-Ipr/Ipr-gld/gld cells fail to trigger Ipr-graft-versus-host disease in syngeneic wild-type recipient mice, but can induce wild-type B cells to make autoantibody

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1778-1784

  Zhu, Bangmin ^a   Beaudette, Britte C ^a   Rifkin, Ian R ^a   Marshak Rothstein, Ann ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti nuclear antibody; Fas ligand; Graft versus host disease; Inflammation; Radiation chimera

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; FAS LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; GENE MUTATION; GRAFT VERSUS HOST REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; WASTING SYNDROME;

ANIMALS; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; FEMALE; GRAFT VS HOST DISEASE; MALE; MICE; MICE, INBRED MRL LPR; MUTAGENESIS; STEM CELLS; T-LYMPHOCYTES; WASTING SYNDROME;

EID: 0034076902     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1778::AID-IMMU1778>3.0.CO;2-D     Document Type: Article

References (35)

1. Cohen, P. L. and Eisenberg, R. A., Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991. 9: 243-269.
2. Watanabe-Fukunaga, R., Brannan, C., Copeland, N., Jenkins, N. and Nagata, S., Lymphproliferative disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 1992. 356: 314.
3. Takahashi, T., Tanaka M., Brannan, C., Jenkins, N., Copeland, N., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994. 76: 969.
4. Fujiwara, M. and Kariyone, A., One-way occurrence of graft-versus-host disease in bone marrow chimeras between congenic MRL mice. Immunology 1984. 53: 251-256.
5. Theofilopoulos, A. N., Balderas, R. S., Gozes, Y., Aguado, M. T., Hang, L., Morrow, P. R. and Dixon, F. J., Association of lpr gene with graft-vs-host disease-like syndrome. J. Exp. Med. 1985. 162: 1-18.
6. Aihara, M., Aihara, Y. and Nakajima, H., Comparison of wasting syndrome in [MRL lpr/lpr → MRL +/+] chimera and graft versus host disease in [B10.D2 → BALB/c] chimera and an attempt to transfer the wasting syndrome in [MRL lpr/lpr → MRL+/+] to MRL +/+ mice. J. Dermatol. Sci. 1994. 7: 107-118.
7. Hosaka, N., Nagata, N., Nakagawa T., Miyashima, S., Yasumizu, R. and Ikehara, S., Analyses of lpr-GVHD by adoptive transfer experiments using MRL/lpr-Thy-1.1 congenic mice. Autoimmunity 1994. 17: 217-224.
8. Allen, R. D., Marshall, J. D., Roths, J. B. and Sidman, C. L., Bone marrow transplantation from mutant lpr/lpr mice. Functional abnormalities rather than alloantigenic differences appear to determine the development of a graft-vs.-host-like syndrome. Eur. J. Immunol. 1990. 20: 2057-2066.
9. Miyashima, S., Nagata, N., Nakagawa, T., Hosaka, N., Takeuchi, K., Ogawa, R. and Ikehara, S., Prevention of lpr-graft-versus-host disease and transfer of autoimmune disease in normal C57BL76 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice. J. Immunol. 1996. 156: 79-84.
10. Via, C. S., Nguyen, P., Shustov, A., Drappa, J. and Elkon, K. B., A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 1996. 157: 5387-5393.
11. Baker, M. B., Riley, R. L., Podack, E. R. and Levy, R. B., Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Proc. Natl. Acad. Sci. USA 1997. 94: 1366-1371.
12. Graubert, T. A., DiPersio, J. F., Russell, J. H. and Ley, T. J., Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J. Clin. Invest. 1997. 100: 904-911.
13. Braun, M. Y., Lowin, B., French, L., Acha-Orbea, H. and Tschopp, J., Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce acute graft-versus-host disease. J. Exp. Med. 1996. 183: 657-661.
14. Bonfoco, E., Stuart, P. M., Brunner, T., Lin, T., Griffith, T. S., Yakun, G., Nakajima, H., Henkart, P. A., Ferguson, T. A. and Green, D. R., Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 1998. 9: 711-720.
15. Montecino-Rodriguez, E. M. and Loor, F., Hematopoietic cell transfers between C57BL/6 mice differing at the lpr or gld locus. Immunology 1991. 74: 127-131.
16. Allen, R. D., Marshall, J. D., Roths, J. B. and Sidman, C. L., Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp. Med. 1990. 172: 1367-1375.
17. Perkins, D. L., Michaelson, J., Glaser, R. M. and Marshak-Rothstein, A., Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease. J. Immunol. 1987. 139: 1406.
18. Mori, T., Nishimura, T., Ikeda, Y., Hotta, T., Yagita, H. and Ando, K., Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression. Blood 1998. 92: 101-107.
19. Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi K., Kayagaki N., Yagita, H. and Okumura, K., Differential effects of anti-Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies. Blood 1998. 91: 4051-4055.
20. Watanabe, D., Suda, T., Hashimoto, H. and Nagata, S., Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 1995. 14: 12-18.
21. Chu, J. L., Ramos, P., Rosendorff, A., Nikolic-Zugic, J., Lacy, E., Matsuzawa A. and Elkon, K. B., Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease like wasting syndrome. J. Exp. Med. 1995. 181: 393-398.
22. Russell, J. H., Rush, B., Weaver, C. and Wang, R., Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 1993. 90: 4409.
23. Russell, J. H. and Wang, R., Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 1993. 23: 2379-2384.
24. Sekine, C., Yagita, H., Kobata, T., Hasunuma, T., Nishioka, K. and Okumura, K., Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of of CPP32-mediated apoptosis. Biochem. Biophys. Res. Commun. 1996. 228: 14.
25. Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S. and Suda, T., Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 1998. 4: 1287-1292.
26. Suzuki, I. and Fink. P. J., Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 1998. 187: 123-128.
27. + T cells. Nat. Med. 1998. 4: 1377-1382.
28. Nemazee, D., Guiet, C., Buerki, K. and Marshak-Rothstein, A., B lymphocytes from the autoimmune-prone mouse strain MRL/ lpr manifest an intrinsic defect in MRL/lpr ↔ DBA/2 chimeras. J. Immunol. 1991. 147: 2536-2539.
29. Katagiri, T., Azuma, S., Toyoda, Y., Mori, S., Kono, K., Cohen, P. L. and Eisenberg, R. A., Tetraparental mice reveal complex cellular interactions of the mutant, autoimunity-inducing lpr gene. J. Immunol. 1992. 148: 430-438.
30. Sobel, E. S., Kakkanaiah, V. N., Cohen, P. L. and Eisenberg, R. A., Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int. Immunol. 1993. 5: 1275-1278.
31. Yasutomo, K., Maeda K., Nagata, S., Nagasawa, H., Okada, K., Good, R. A., Kuroda, Y. and Himeno, K., Defective T cells from gld mice play a pivitol role in development of Thy1.2+B220+ cells and autoimmunity. J. Immunol. 1994. 153: 5855-5864.
32. MacDonald, G. C., Kakkanaiah, V. N., Sobel, E. S., Cohen, P. L. and Eisenberg, R. A., In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras. J. Immunol. 1995. 154: 444-449.
33. + T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL. Cell. Immunol. 1997. 179: 153-164.
34. Perkins, D. L., Michaelson, J. and Marshak-Rothstein, A., The lpr gene is associated with resistance to engraftment by lymphoid but not erythroid stem cells from normal mice. J. Immunol. 1987. 138: 466-469.
35. Rifkin I. R., Channavajhala, P. L., Kiefer, H. L. B., Carmack, A. J., Landesman-Bollag, E., Beaudette, B. C., Jersky, B., Salant, D., Ju, S.-T., Marshak-Rothstein, A. and Seldin, D., Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2α. J. Immunol. 1998. 161: 5164-5170.